Elon Musk has initiated legal action against OpenAI’s co-founder, alleging a shift away from the organization’s initial commitment to prioritize the development of safe artificial intelligence (AI) over profit-making.
OpenAI Employees Demand Resignation of Board Members
Close to 500 employees at OpenAI, the organization behind ChatGPT, have allegedly penned a letter to their superiors, stating their intention to leave the company if the current board does
OpenAI, the company behind ChatGPT, pauses new client acquisitions amid soaring demand challenges.
ChatGPT’s parent company, OpenAI, has temporarily stopped accepting new sign-ups due to challenges in coping with the rapidly increasing demand for its AI technology, as reported by Matthew Field.
OpenAI, the developer of ChatGPT, has experienced a tripling in valuation since the beginning of the year.
Since the start of the year, OpenAI, the entity behind ChatGPT, has witnessed its valuation soar threefold, reaching at least US$80 billion, based on reports surrounding ongoing discussions with investors.
ChatGPT now possesses the ability to engage in audible conversation, hearing & responding to you.
Late last year, the digital chatbot ChatGPT made quite an impression globally, and now, it’s back with additional capabilities. OpenAI has enhanced its bot to speak, listen, and “see” the
EU Legislators Express Dissatisfaction Towards the Creator of ChatGPT
EU policymakers drafting a bill on AI regulation have expressed their disagreement with remarks made by OpenAI CEO, Sam Altman, during his visit to meet authorities across Europe.
ChatGPT possesses superior stock selection capabilities compared to traditional fund managers.
A collection of stocks curated by ChatGPT, an AI-driven chatbot, has significantly outperformed several well-known investment funds in the UK.
Pfizer and Moderna’s encouraging COVID-19 vaccine update makes bank stocks look attractive
The Case For Buying Bank Stocks Is Based On Encouraging Vaccine Updates
Pfizer and Moderna’s encouraging COVID-19 vaccine update makes bank stocks look attractive
The Case For Buying Bank Stocks Is Based On Encouraging Vaccine Updates
Pfizer and Moderna’s encouraging COVID-19 vaccine update makes bank stocks look attractive
The Case For Buying Bank Stocks Is Based On Encouraging Vaccine Updates